Dr Liam Heaney is a professor of respiratory medicine at Queen’s University Belfast (UK) and a consultant physician at Belfast…
In 2014, the first guidelines for the treatment of severe asthma in children and adults were composed by the European…
Fokkens W et al. EUFOREA consensus on biologics for CRSwNP with or without asthma. Allergy. 2019;74:2312–2319. Chronic rhinosinusitis with nasal…
Alving K, Diamant Z, Lucas S, et al. Point‐of‐care biomarkers in asthma management: Time to move forward Allergy. Allergy. 2020;75(4):995‐997.…
In the past 15 years, striking progress has been made in our understanding of the mechanisms underlying chronic inflammatory airway…
IL-1⍺ blockade is a novel interesting target in atopic dermatitis (AD). In a proof-of-concept study, an IL-1 blocker improved AD…
In addition to skin clearance, baricitinib in combination with topical corticosteroid (TCS) showed to be particularly effective in pruritus reduction…
Biologics and cytokine blockers are increasingly used in children and adolescents with moderate-to-severe psoriasis and atopic dermatitis (AD). Data shows…
A post-hoc analysis of the phase 3 trial LIBERTY AD ADOL showed that dupilumab entails a rapid itch reduction after…
Immune dysfunction and epidermal barrier dysfunction are two key factors in the atopic dermatitis (AD) pathogenesis. “In my belief, the…